Share Price and Basic Stock Data
Last Updated: March 12, 2025, 1:59 pm
PEG Ratio | -53.96 |
---|
Competitors of Deepak Nitrite Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Fischer Medical Ventures Ltd | 4,299 Cr. | 804 | 907/454 | 1,919 | 15.2 | 0.00 % | 5.25 % | 4.55 % | 10.0 |
Emmessar Biotech & Nutrition Ltd | 17.7 Cr. | 35.4 | 64.0/27.2 | 23.3 | 15.6 | 0.00 % | 11.4 % | 10.6 % | 10.0 |
Cochin Minerals & Rutile Ltd | 200 Cr. | 256 | 415/239 | 18.0 | 198 | 3.13 % | 26.6 % | 5.82 % | 10.0 |
Archean Chemical Industries Ltd | 6,755 Cr. | 547 | 832/408 | 30.9 | 143 | 0.54 % | 25.8 % | 19.4 % | 2.00 |
Alufluoride Ltd | 326 Cr. | 417 | 581/341 | 14.6 | 122 | 0.72 % | 25.1 % | 22.2 % | 10.0 |
Industry Average | 5,302.75 Cr | 513.75 | 217.72 | 146.20 | 0.53% | 15.23% | 10.70% | 7.82 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,722 | 1,872 | 2,058 | 1,962 | 1,991 | 1,961 | 1,768 | 1,778 | 2,009 | 2,126 | 2,167 | 2,032 | 1,903 |
Expenses | 1,370 | 1,462 | 1,702 | 1,691 | 1,676 | 1,613 | 1,559 | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 |
Operating Profit | 352 | 410 | 356 | 271 | 315 | 348 | 210 | 302 | 305 | 301 | 309 | 298 | 169 |
OPM % | 20% | 22% | 17% | 14% | 16% | 18% | 12% | 17% | 15% | 14% | 14% | 15% | 9% |
Other Income | 26 | 4 | 10 | 12 | 13 | 13 | 32 | 17 | 14 | 99 | 19 | 21 | 21 |
Interest | 7 | 7 | 9 | 6 | 6 | 4 | 2 | 3 | 3 | 4 | 6 | 6 | 6 |
Depreciation | 45 | 45 | 42 | 42 | 41 | 41 | 38 | 39 | 42 | 46 | 47 | 48 | 48 |
Profit before tax | 325 | 362 | 315 | 235 | 281 | 315 | 202 | 277 | 274 | 349 | 275 | 264 | 135 |
Tax % | 25% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 27% |
Net Profit | 242 | 267 | 235 | 174 | 209 | 234 | 150 | 205 | 202 | 254 | 203 | 194 | 98 |
EPS in Rs | 17.78 | 19.59 | 17.20 | 12.79 | 15.33 | 17.15 | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 |
Last Updated: March 3, 2025, 4:47 pm
Below is a detailed analysis of the quarterly data for Deepak Nitrite Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,903.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,032.00 Cr. (Sep 2024) to ₹1,903.00 Cr., marking a decrease of 129.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹1,735.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,734.00 Cr. (Sep 2024) to ₹1,735.00 Cr., marking an increase of ₹1.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹169.00 Cr.. The value appears to be declining and may need further review. It has decreased from 298.00 Cr. (Sep 2024) to ₹169.00 Cr., marking a decrease of 129.00 Cr..
- For OPM %, as of Dec 2024, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Sep 2024) to 9.00%, marking a decrease of 6.00%.
- For Other Income, as of Dec 2024, the value is ₹21.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 21.00 Cr..
- For Interest, as of Dec 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 6.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹48.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 48.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹135.00 Cr.. The value appears to be declining and may need further review. It has decreased from 264.00 Cr. (Sep 2024) to ₹135.00 Cr., marking a decrease of 129.00 Cr..
- For Tax %, as of Dec 2024, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Sep 2024) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Dec 2024, the value is ₹98.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Sep 2024) to ₹98.00 Cr., marking a decrease of 96.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 7.19. The value appears to be declining and may need further review. It has decreased from ₹14.24 (Sep 2024) to 7.19, marking a decrease of ₹7.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:29 pm
Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,228 |
Expenses | 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,152 |
Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,076 |
OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% |
Other Income | 1 | -0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 160 |
Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 23 |
Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 191 |
Profit before tax | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 1,023 |
Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | |
Net Profit | 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 749 |
EPS in Rs | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 54.89 |
Dividend Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% |
YoY Net Profit Growth
Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 18.87% | 52.38% | -17.71% | 120.25% | 251.15% | 27.00% | 37.50% | -20.15% | -4.81% |
Change in YoY Net Profit Growth (%) | 0.00% | 33.51% | -70.09% | 137.96% | 130.90% | -224.14% | 10.50% | -57.65% | 15.34% |
Deepak Nitrite Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 21% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | -2% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | 40% |
5 Years: | 33% |
3 Years: | -2% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 28% |
3 Years: | 24% |
Last Year: | 16% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 12:38 am
Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,061 |
Borrowings | 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 857 |
Other Liabilities | 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,063 |
Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,009 |
Fixed Assets | 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,404 |
CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,169 |
Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 394 |
Other Assets | 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,042 |
Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,009 |
Below is a detailed analysis of the balance sheet data for Deepak Nitrite Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹27.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹5,061.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹4,769.00 Cr. (Mar 2024) to ₹5,061.00 Cr., marking an increase of 292.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹857.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹286.00 Cr. (Mar 2024) to ₹857.00 Cr., marking an increase of 571.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹1,063.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,012.00 Cr. (Mar 2024) to ₹1,063.00 Cr., marking an increase of 51.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹7,009.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹6,095.00 Cr. (Mar 2024) to ₹7,009.00 Cr., marking an increase of 914.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹2,404.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,293.00 Cr. (Mar 2024) to ₹2,404.00 Cr., marking an increase of 111.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1,169.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹774.00 Cr. (Mar 2024) to ₹1,169.00 Cr., marking an increase of 395.00 Cr..
- For Investments, as of Sep 2024, the value is ₹394.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹122.00 Cr. (Mar 2024) to ₹394.00 Cr., marking an increase of 272.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹3,042.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,907.00 Cr. (Mar 2024) to ₹3,042.00 Cr., marking an increase of 135.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹7,009.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6,095.00 Cr. (Mar 2024) to ₹7,009.00 Cr., marking an increase of 914.00 Cr..
Notably, the Reserves (₹5,061.00 Cr.) exceed the Borrowings (857.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -405.00 | -360.00 | -585.00 | -783.00 | 420.00 | 0.00 | -589.00 | -314.00 | -72.00 | -285.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 |
Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 |
Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 41 |
Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 74 |
Working Capital Days | 60 | 43 | 51 | 44 | 70 | 55 | 62 | 63 | 71 | 70 |
ROCE % | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Motilal Oswal Midcap Fund | 1,500,000 | 2.97 | 375.29 | 900,000 | 2025-03-11 | 66.67% |
Franklin India Smaller Companies Fund | 1,387,967 | 2.48 | 347.26 | 900,000 | 2025-03-11 | 54.22% |
Franklin India Prima Fund | 1,100,123 | 2.29 | 275.25 | 900,000 | 2025-03-11 | 22.24% |
Nippon India Small Cap Fund | 1,000,000 | 0.44 | 250.2 | 900,000 | 2025-03-11 | 11.11% |
Motilal Oswal Flexi Cap Fund | 900,000 | 2.02 | 225.18 | 900,000 | 2025-03-11 | 0% |
Franklin India Focused Equity Fund | 767,769 | 1.57 | 192.09 | 900,000 | 2025-03-11 | -14.69% |
Mirae Asset Large & Midcap Fund | 747,824 | 0.49 | 187.1 | 900,000 | 2025-03-11 | -16.91% |
Nippon India Growth Fund | 593,778 | 0.48 | 148.56 | 900,000 | 2025-03-11 | -34.02% |
Sundaram Mid Cap Fund | 517,174 | 1.09 | 129.39 | 900,000 | 2025-03-11 | -42.54% |
Sundaram Mid Cap Fund - Institutional Plan | 517,174 | 1.09 | 129.39 | 900,000 | 2025-03-11 | -42.54% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 59.45 | 62.46 | 78.20 | 56.88 | 44.80 |
Diluted EPS (Rs.) | 59.45 | 62.46 | 78.20 | 56.88 | 44.80 |
Cash EPS (Rs.) | 71.59 | 74.66 | 91.23 | 68.07 | 55.04 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 353.57 | 299.85 | 244.75 | 172.04 | 115.24 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 353.57 | 299.85 | 244.75 | 172.04 | 115.24 |
Revenue From Operations / Share (Rs.) | 563.18 | 584.46 | 498.69 | 319.63 | 310.10 |
PBDIT / Share (Rs.) | 87.93 | 98.02 | 120.69 | 93.00 | 77.79 |
PBIT / Share (Rs.) | 75.79 | 85.83 | 107.66 | 81.81 | 67.54 |
PBT / Share (Rs.) | 80.77 | 84.01 | 105.16 | 76.37 | 59.12 |
Net Profit / Share (Rs.) | 59.45 | 62.46 | 78.20 | 56.88 | 44.80 |
NP After MI And SOA / Share (Rs.) | 59.45 | 62.46 | 78.20 | 56.88 | 44.80 |
PBDIT Margin (%) | 15.61 | 16.77 | 24.20 | 29.09 | 25.08 |
PBIT Margin (%) | 13.45 | 14.68 | 21.58 | 25.59 | 21.78 |
PBT Margin (%) | 14.34 | 14.37 | 21.08 | 23.89 | 19.06 |
Net Profit Margin (%) | 10.55 | 10.68 | 15.68 | 17.79 | 14.44 |
NP After MI And SOA Margin (%) | 10.55 | 10.68 | 15.68 | 17.79 | 14.44 |
Return on Networth / Equity (%) | 16.90 | 20.83 | 31.95 | 33.06 | 38.87 |
Return on Capital Employeed (%) | 19.46 | 27.00 | 39.86 | 37.11 | 37.45 |
Return On Assets (%) | 13.30 | 16.61 | 24.07 | 21.79 | 19.04 |
Long Term Debt / Equity (X) | 0.04 | 0.01 | 0.05 | 0.22 | 0.49 |
Total Debt / Equity (X) | 0.04 | 0.01 | 0.09 | 0.24 | 0.65 |
Asset Turnover Ratio (%) | 1.37 | 0.81 | 0.80 | 0.67 | 0.89 |
Current Ratio (X) | 3.62 | 3.45 | 3.06 | 2.62 | 1.54 |
Quick Ratio (X) | 2.65 | 2.33 | 2.28 | 1.93 | 1.02 |
Inventory Turnover Ratio (X) | 6.67 | 3.81 | 4.20 | 3.02 | 3.20 |
Dividend Payout Ratio (NP) (%) | 12.61 | 11.20 | 7.03 | 0.00 | 14.50 |
Dividend Payout Ratio (CP) (%) | 10.47 | 9.37 | 6.02 | 0.00 | 11.80 |
Earning Retention Ratio (%) | 87.39 | 88.80 | 92.97 | 0.00 | 85.50 |
Cash Earning Retention Ratio (%) | 89.53 | 90.63 | 93.98 | 0.00 | 88.20 |
Interest Coverage Ratio (X) | 101.38 | 53.95 | 48.36 | 17.10 | 9.24 |
Interest Coverage Ratio (Post Tax) (X) | 62.80 | 35.38 | 32.33 | 11.46 | 6.32 |
Enterprise Value (Cr.) | 28716.86 | 25144.18 | 30869.10 | 23144.91 | 6269.67 |
EV / Net Operating Revenue (X) | 3.74 | 3.15 | 4.54 | 5.31 | 1.48 |
EV / EBITDA (X) | 23.94 | 18.81 | 18.75 | 18.25 | 5.91 |
MarketCap / Net Operating Revenue (X) | 3.77 | 3.15 | 4.50 | 5.18 | 1.25 |
Retention Ratios (%) | 87.38 | 88.79 | 92.96 | 0.00 | 85.49 |
Price / BV (X) | 6.03 | 6.14 | 9.17 | 9.63 | 3.35 |
Price / Net Operating Revenue (X) | 3.77 | 3.15 | 4.50 | 5.18 | 1.25 |
EarningsYield | 0.02 | 0.03 | 0.03 | 0.03 | 0.11 |
After reviewing the key financial ratios for Deepak Nitrite Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 59.45. This value is within the healthy range. It has decreased from 62.46 (Mar 23) to 59.45, marking a decrease of 3.01.
- For Diluted EPS (Rs.), as of Mar 24, the value is 59.45. This value is within the healthy range. It has decreased from 62.46 (Mar 23) to 59.45, marking a decrease of 3.01.
- For Cash EPS (Rs.), as of Mar 24, the value is 71.59. This value is within the healthy range. It has decreased from 74.66 (Mar 23) to 71.59, marking a decrease of 3.07.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 353.57. It has increased from 299.85 (Mar 23) to 353.57, marking an increase of 53.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 353.57. It has increased from 299.85 (Mar 23) to 353.57, marking an increase of 53.72.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 563.18. It has decreased from 584.46 (Mar 23) to 563.18, marking a decrease of 21.28.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 87.93. This value is within the healthy range. It has decreased from 98.02 (Mar 23) to 87.93, marking a decrease of 10.09.
- For PBIT / Share (Rs.), as of Mar 24, the value is 75.79. This value is within the healthy range. It has decreased from 85.83 (Mar 23) to 75.79, marking a decrease of 10.04.
- For PBT / Share (Rs.), as of Mar 24, the value is 80.77. This value is within the healthy range. It has decreased from 84.01 (Mar 23) to 80.77, marking a decrease of 3.24.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 59.45. This value is within the healthy range. It has decreased from 62.46 (Mar 23) to 59.45, marking a decrease of 3.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 59.45. This value is within the healthy range. It has decreased from 62.46 (Mar 23) to 59.45, marking a decrease of 3.01.
- For PBDIT Margin (%), as of Mar 24, the value is 15.61. This value is within the healthy range. It has decreased from 16.77 (Mar 23) to 15.61, marking a decrease of 1.16.
- For PBIT Margin (%), as of Mar 24, the value is 13.45. This value is within the healthy range. It has decreased from 14.68 (Mar 23) to 13.45, marking a decrease of 1.23.
- For PBT Margin (%), as of Mar 24, the value is 14.34. This value is within the healthy range. It has decreased from 14.37 (Mar 23) to 14.34, marking a decrease of 0.03.
- For Net Profit Margin (%), as of Mar 24, the value is 10.55. This value exceeds the healthy maximum of 10. It has decreased from 10.68 (Mar 23) to 10.55, marking a decrease of 0.13.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.55. This value is within the healthy range. It has decreased from 10.68 (Mar 23) to 10.55, marking a decrease of 0.13.
- For Return on Networth / Equity (%), as of Mar 24, the value is 16.90. This value is within the healthy range. It has decreased from 20.83 (Mar 23) to 16.90, marking a decrease of 3.93.
- For Return on Capital Employeed (%), as of Mar 24, the value is 19.46. This value is within the healthy range. It has decreased from 27.00 (Mar 23) to 19.46, marking a decrease of 7.54.
- For Return On Assets (%), as of Mar 24, the value is 13.30. This value is within the healthy range. It has decreased from 16.61 (Mar 23) to 13.30, marking a decrease of 3.31.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 23) to 0.04, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.04. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.04, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.37. It has increased from 0.81 (Mar 23) to 1.37, marking an increase of 0.56.
- For Current Ratio (X), as of Mar 24, the value is 3.62. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 23) to 3.62, marking an increase of 0.17.
- For Quick Ratio (X), as of Mar 24, the value is 2.65. This value exceeds the healthy maximum of 2. It has increased from 2.33 (Mar 23) to 2.65, marking an increase of 0.32.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.67. This value is within the healthy range. It has increased from 3.81 (Mar 23) to 6.67, marking an increase of 2.86.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 12.61. This value is below the healthy minimum of 20. It has increased from 11.20 (Mar 23) to 12.61, marking an increase of 1.41.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.47. This value is below the healthy minimum of 20. It has increased from 9.37 (Mar 23) to 10.47, marking an increase of 1.10.
- For Earning Retention Ratio (%), as of Mar 24, the value is 87.39. This value exceeds the healthy maximum of 70. It has decreased from 88.80 (Mar 23) to 87.39, marking a decrease of 1.41.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.53. This value exceeds the healthy maximum of 70. It has decreased from 90.63 (Mar 23) to 89.53, marking a decrease of 1.10.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 101.38. This value is within the healthy range. It has increased from 53.95 (Mar 23) to 101.38, marking an increase of 47.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 62.80. This value is within the healthy range. It has increased from 35.38 (Mar 23) to 62.80, marking an increase of 27.42.
- For Enterprise Value (Cr.), as of Mar 24, the value is 28,716.86. It has increased from 25,144.18 (Mar 23) to 28,716.86, marking an increase of 3,572.68.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 3.15 (Mar 23) to 3.74, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 24, the value is 23.94. This value exceeds the healthy maximum of 15. It has increased from 18.81 (Mar 23) to 23.94, marking an increase of 5.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.77. This value exceeds the healthy maximum of 3. It has increased from 3.15 (Mar 23) to 3.77, marking an increase of 0.62.
- For Retention Ratios (%), as of Mar 24, the value is 87.38. This value exceeds the healthy maximum of 70. It has decreased from 88.79 (Mar 23) to 87.38, marking a decrease of 1.41.
- For Price / BV (X), as of Mar 24, the value is 6.03. This value exceeds the healthy maximum of 3. It has decreased from 6.14 (Mar 23) to 6.03, marking a decrease of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.77. This value exceeds the healthy maximum of 3. It has increased from 3.15 (Mar 23) to 3.77, marking an increase of 0.62.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deepak Nitrite Ltd:
- Net Profit Margin: 10.55%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.46% (Industry Average ROCE: 15.23%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.9% (Industry Average ROE: 10.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 62.8
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 38.3 (Industry average Stock P/E: 217.72)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.55%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Chemicals - Inorganic - Others | 2nd Floor, Fermenter House, Alembic City, Vadodra Gujarat 390003 | investor@godeepak.com http://www.godeepak.com |
Management | |
---|---|
Name | Position Held |
Mr. Deepak C Mehta | Chairman & Managing Director |
Mr. Maulik D Mehta | Executive Director & CEO |
Mr. Sanjay Upadhyay | Director & Group CFO |
Mr. Ajay C Mehta | Non Executive Director |
Mr. Meghav Mehta | Non Executive Director |
Mr. Girish Satarkar | Executive Director |
Mr. Prakash Samudra | Independent Director |
Mr. Vipul Shah | Independent Director |
Mr. Punit Lalbhai | Independent Director |
Mrs. Purvi Sheth | Independent Director |
Mr. Sanjay Asher | Independent Director |
Mr. Dileep Choksi | Independent Director |
FAQ
What is the latest intrinsic value of Deepak Nitrite Ltd?
The latest intrinsic value of Deepak Nitrite Ltd as on 12 March 2025 is ₹1881.62, which is 2.96% lower than the current market price of ₹1,939.00, indicating the stock is overvalued by 2.96%. The intrinsic value of Deepak Nitrite Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹26,445 Cr. and recorded a high/low of ₹3,169/1,790 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹5,061 Cr and total liabilities of ₹7,009 Cr.
What is the Market Cap of Deepak Nitrite Ltd?
The Market Cap of Deepak Nitrite Ltd is 26,445 Cr..
What is the current Stock Price of Deepak Nitrite Ltd as on 12 March 2025?
The current stock price of Deepak Nitrite Ltd as on 12 March 2025 is ₹1,939.
What is the High / Low of Deepak Nitrite Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Deepak Nitrite Ltd stocks is ₹3,169/1,790.
What is the Stock P/E of Deepak Nitrite Ltd?
The Stock P/E of Deepak Nitrite Ltd is 38.3.
What is the Book Value of Deepak Nitrite Ltd?
The Book Value of Deepak Nitrite Ltd is 373.
What is the Dividend Yield of Deepak Nitrite Ltd?
The Dividend Yield of Deepak Nitrite Ltd is 0.39 %.
What is the ROCE of Deepak Nitrite Ltd?
The ROCE of Deepak Nitrite Ltd is 21.6 %.
What is the ROE of Deepak Nitrite Ltd?
The ROE of Deepak Nitrite Ltd is 16.4 %.
What is the Face Value of Deepak Nitrite Ltd?
The Face Value of Deepak Nitrite Ltd is 2.00.